Where We Stand
Section: Prescribing Guidelines
Policy: Prescription Writing of Non-Controlled Substances

Prescription Writing of Non-Controlled Substances

The following guidelines for prescription writing are intended to go beyond the minimal requirements of the law. Tempered with good moral and ethical judgment, they are for the purpose of enhancing patient care.

  • The written prescription order should be precise and distinctly legible to assure exact and effective communication between prescriber and dispenser.
  • Although the prescriber must provide his/her DEA number, preprinting the number on prescription forms is to be discouraged as this facilitates forgeries.
  • When indicating refills, write out the proper instructions in addition to marking the appropriate box, as this section can be altered easily.
  • Try to make prescription orders alteration proof. When prescribing a controlled substance, write out the actual amount, e.g., "Twenty (20) only" in order to allay attempts at alterations.
  • The practice of preprinting prescription blanks with a "check-off" for the amount of the order (e.g., __ 1-10; __ 10-20, etc.) is not encouraged.
  • The use of prescription blanks with proprietary names preprinted is discouraged.
  • Proper security procedures for the storage and handling of blank prescription order pads should be instituted and followed. A common method of diversion of pharmaceuticals to illicit use is through the theft and subsequent forgery of prescription pads. Prescribers should keep extra pads in a locked drawer and should never leave pads unattended in an examination room.
  • Use a separate prescription blank for each controlled substance prescribed.
  • Prescribe no greater quantity of a controlled substance than is needed until the next check-up.
  • Each prescriber should have his/her own individual prescription blanks. Printing with multiple names is not encouraged.
  • If institutional blanks are used, the prescriber should print his/her own name, address and DEA registration number on the blanks.
  • Institutions should discourage the use of institutional blanks for prescribing controlled substances. The prescriber should use his/her own blanks for this purpose.

Reaffirmed at the interim House of Delegates, 2004.

Return to the Where We Stand table of contents.